At a glance
ClinicalIndex Comparison RecordN/ACompleted· 350 enrolled
Drug / intervention
intensive monitoringprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Concurrent Tuberculosis and Diabetes: Clinical Monitoring, and Microbiological and Immunological Effects of Diabetes During Tuberculosis Treatment
In Brief
A clinical study evaluating intensive monitoring for Diabetes Mellitus and Pulmonary Tuberculosis. Completed, enrolled 350 participants across 3 sites in 3 countries.
Detailed Summary
The purpose of this study is to evaluate the effect of enhanced glycemic monitoring of diabetes upon diabetes glycaemic control during tuberculosis treatment in tuberculosis- diabetes patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Pulmonary Tuberculosis
CountriesIndonesia, Peru, Romania
CollaboratorsLondon School of Hygiene and Tropical Medicine, Radboud University Medical Center, Leiden University Medical Center, University of Stellenbosch, St George's, University of London, University of Otago, University of Medicine and Pharmacy Craiova, University Medical Center Groningen, Universidad Peruana Cayetano Heredia
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 2014
Enrollment StartApr 2014
Primary CompletionFeb 2017
Study CompletionDec 2017
TodayJul 2026
First PostedApr 7, 2014
Enrollment StartApr 28, 2014
Primary CompletionFeb 21, 2017
Study CompletionDec 21, 2017
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 12.2 years ago
Interventions
intensive monitoringprocedure